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A complicated urinary tract infection (UTI) has relapsing and refractory characteristics, and is sometimes
life-threatening because of patient predisposing factors as well as the recent worldwide spread of multi-
drug resistant bacteria. Patients with complicated UTI should be treated with effective antimicrobial
therapy along with appropriate urological intervention to remove predisposing factors when the
symptoms are associated. By contrast, routine use of antimicrobial prophylaxis for asymptomatic
bacteriuria (ASB) is not recommended, as that would contribute to an increase in even more resistant
pathogens. Here, four classiﬁcations of complicated UTI, which are considered to be clinically important
for general urologists, are reviewed, including UTI in patients with diabetes mellitus (DM) and those with
a neurogenic bladder, as well as catheter-associated UTI (CAUTI) and obstructive pyelonephritis sec-
ondary to urolithiasis. Appropriate treatment approaches can only be chosen by proper understanding of
the etiologies of complicated UTI, as well as correct diagnostic strategies and treatment options.
Copyright © 2016, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A complicated urinary tract infection (UTI), which can involve
either the bladder or kidneys, is a symptomatic urinary infection
that occurs in individuals with functional or structural abnormal-
ities of the genitourinary tract.1 Patients with complicated UTI
should be treated by effective antimicrobial therapy as well as
appropriate urological intervention to remove predisposing factors
when the symptoms are associated, such as micturition pain,
dysuria, urinary frequency, and low or high fever. By contrast,
asymptomatic bacteriuria (ASB) or asymptomatic pyuria is identi-
ﬁed by isolation of a speciﬁed quantiﬁable amount of bacteria in an
appropriately collected urine specimen obtained from a patient
without symptoms or signs referable to urinary infection.2 Although
ASB is usually observed in diabetic women and older individuals, as
well as patients with spinal cord injury or an indwelling catheter,
routine screening for or treatment of ASB is not recommended.32. UTI in patients with diabetes mellitus
The prevalence of ASB is three times greater in women with
diabetes mellitus (DM) as compared with those without DM.4 Inogo College of Medicine, 1-1
.
ociation. Published by Elsevier Ta
to S, Prevention and treatmethat study, 26% of nonpregnant female DM patients had signiﬁcant
bacteriuria (> 105 cfu/mL) as compared with only 6% of the control
population. Recently, the signiﬁcance of ASB in patients with DM
was addressed in a placebo-controlled, double-blind randomized
trial, which concluded that antimicrobial treatment did not reduce
the incidence of cystitis,5 indicating that the presence of diabetes
should not be regarded as an indication for screening or treatment
of ASB. However, women with DM are at greater risk of both
symptomatic and asymptomatic UTI, although that risk is increased
by threeefour-fold in females taking oral hypoglycemics or with
insulin-controlled DM, indicating a possible association between
increased incidence of UTI and severity of DM.6 Furthermore, UTI in
patients with DM is difﬁcult to treat and often recurs, with those
patients also reported to have a 40% increased risk of recurrent
cystitis.7 Complications associated with symptomatic UTI are also
increased in patients with DM, and women with type 1 DM have
increased risk of developing pyelonephritis and subsequent
impaired renal function.8 In addition, neuropathy is a common
complication in diabetic patients as the prevalence of neuropathy is
estimated to be ~8% in newly diagnosed patients and > 50% in
patients with long-standing disease. Genitourinary autonomic
neuropathy can cause bladder dysfunction as a voiding problem
characterized by poor emptying which could give rise to suscepti-
bility to UTI.9
Emphysematous pyelonephritis (EPN) is a severe necrotizing
form of acute multifocal bacterial nephritis that results in the
presence of gas within the renal parenchyma, with underlyingiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
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patients.10 A common clinical trial of predisposing factors is DM,
remote or recent kidney infection, and obstruction. It was found
that between 85% and 100% of patients with EPN are diabetics, and
~40% have an obstruction most commonly caused by calculi, which
is bilateral in 10% of the cases.11 However, diagnosis of EPN is often
delayed because of nonspeciﬁc clinical manifestations. Computed
tomography (CT) is the preferred method for diagnosis, because of
its high sensitivity and speciﬁcity for detection of abnormal gas and
its anatomical extension.12 A meta-analysis showed CT was accu-
rate for detecting EPN in all 628 cases, whilst the accuracy rate for
plain radiography was 53.2% and for ultrasonography was 67.9%,
indicating that, once EPN is suspected, CT must not be delayed to
conﬁrm the diagnosis.13 Treatment of EPN involves broad-spectrum
antimicrobial therapy, hyperglycemic control, and adequate urinary
drainage with correction of any outlet obstruction. Patients with a
necrotizing infection will require a more aggressive treatment
approach that includes surgery.10,14 Once a diagnosis is made,
prompt decisions must be made as to whether to give medical
therapy alone, or that with percutaneous drainage or a nephrec-
tomy. To evaluate the prognostic factors of cases with EPN, two
classiﬁcation systems has been reported by Wan et al15 and Huang
et al.16 The former reported that patients with creatinine levels >
1.4 mg/dL and platelet counts  60,000/mm3 were at high risk,15
although later reported that patients with two or more risk fac-
tors (altered consciousness, thrombocytopenia, shock, acute renal
failure) require aggressive treatment.16
Sodium-glucose transport proteins (SGLTs) have recently
become a topic of signiﬁcant interest in the ﬁeld of type 2 diabetes.
SGLT-2 inhibitors block reabsorption of ﬁltered glucose, leading to
glucosuria and improvement in glycemic control, although they are
also associated with caloric loss, which has the potential to lead to
weight loss.17 In patients using an SGLT-2 inhibitor, glucose in the
urine may encourage bacteria in the urinary tract to ﬂourish,
resulting in infection. Although several studies have shown
increased incidence of UTI in patients taking an SGLT-2 inhibitor,
others have reported that such treatment is accompanied by
increased risk of genital infection, such as vulvovaginitis or bal-
anitis, rather than UTI, which is related to induction of glucosuria.18
3. UTI with a neurogenic bladder
UTI in patients with a neurogenic bladder is characterized by
clinical symptoms as well as laboratory ﬁndings of leukocyturia,
bacteriuria, and positive urine culture. For diagnosis, a urine spec-
imen should be obtained by a clean-catchmidstream technique, via
a newly inserted catheter, or bladder puncture. However, pyuria
and bacteriuria have low speciﬁcity, because ASB is not rare in
patients with a neurogenic bladder. Also, because of sensory and
motor nerve paralysis, UTI in neurogenic bladder patients shows
atypical symptomatology, including malaise and lethargy, new or
increased urine leakage, increased spasticity, autonomic dysre-
ﬂexia, loin pain, suprapubic pain, and dysuria.19,20
The spectrum of pathogens causing UTI in patients with a
neurogenic bladder differs from that in patients with normal
bladder function and is much broader. The majority of UTIs are
generally caused by Gram-negative bacilli and enterococci, though
sometimes by exogenous bacteria from the hospital environment
and often by polymicrobial pathogens. Thus, urine culture and
susceptibility testing should be performed before initiating anti-
microbial therapy.21 For selection of antimicrobial agents, regional
differences in antibiotic resistance patterns must be taken into
consideration.22 The optimal duration of antimicrobial therapy
ranges generally from 5 days to 14 days depending on severity, with
7 days most commonly used.21,23Please cite this article in press as: Yamamoto S, Prevention and treatme
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the method used for bladder emptying is the most important issue.
A lower rate of UTI and fewer complications are associated with
intermittent catheterization as compared with indwelling urethral
catheterization, supporting the notion that clean intermittent
catheterization (CIC) is the best voiding method for reducing
bacteriuria and urinary tract infections in patients with a neuro-
genic bladder.24,25 Thus, CIC should be employed as a standard
routine treatment for patients unable to empty their bladder.
Furthermore, some reports have suggested that CIC using a
hydrophilic-coated or prelubricated catheter may have additional
advantages for reducing the risk of UTI in patients with spinal cord
injury.26,27
Some studies have reported beneﬁcial effects of antimicrobial
prophylaxis in patients with a neurogenic bladder when givenwith
a limited duration and under restricted conditions.28 However, that
therapy is generally not recommended, because its beneﬁts are
unproven and it has been associated with development of antimi-
crobial resistance.21,22
Bladder management in patients with neurogenic bladder,
especially with spinal cord injury, includes not only bladder
emptying by CIC but also effective pharmacologic therapy of
neurogenic detrusor overactivity, using oral antimuscarinics.29
Recently intradetrusor injections of botulinum toxin is applied in
antimuscarinic refractory cases although this treatment has not
been supported by a high level of evidence studies.30 A spinal cord
lesion also can cause concomitant neurological bowel dysfunction,
resulting in constipation and fecal incontinence. Bowel manage-
ment aimed at regular emptying of the bowels often relieves con-
stipation and fecal soiling, and also reduces the risk of UTI.31
4. Catheter-associated UTI
Catheter-associated UTI (CAUTI) is generally deﬁned as UTI
associated with an indwelling urinary catheter; i.e., a drainage tube
inserted into the urinary bladder through the urethra. A surveil-
lance study conducted over a 6-year period by the International
Nosocomial Infection Control Consortium of 422 intensive care unit
(ICU) cases in 36 countries, 57% of which were in Asia, found that
developing countries had a rate of 6.3 cases of CAUTI per 1000
urinary catheter-days, as comparedwith 3.3 per 1000 catheter-days
in comparable ICU cases treated in the United States.32 CAUTI in
developing countries is also associated with a higher rate of anti-
biotic resistance shown by microbiological surveillance.
Bioﬁlm that develops on a urinary catheter provides a favorable
environment for bacterial proliferation and invasion. Bacteria can
be introduced into the urinary tract via several routes, such as
inoculation at the time of catheter insertion, an intraluminal ascent
in the urinary catheter lumen, or an extraluminal route of ascent
along the external surface of the urinary catheter.33 Risk factors for
CAUTI identiﬁed in prospective observational studies include
duration of catheterization, female gender, anatomical or func-
tional abnormalities of the urinary tract, insertion of the catheter
outside the operating room, DM, poor catheter care, and breaks in
the aseptic technique.34e37 The most common uropathogen iso-
lated is Escherichia coli, although other common enteric organisms
have been isolated from patients who received short-term cathe-
terization. Proteus mirabilis bacteriuria is often associated with
catheter obstruction, although polymicrobial bacteriuria is
commonly found in patients with long-term catheter use.38
The symptoms of CAUTI may include several signs, such as fever,
hematuria, bladder irritability, suprapubic pain, and costovertebral
angle tenderness indicating cystitis, as well as pyelonephritis,
prostatitis, or epididymitis. However, distinction from catheter-
associated ASB may be difﬁcult in patients with a spinal cordnt of complicated urinary tract infection, Urological Science (2016),
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ities, or extreme age.39 Thus, a carefully performed physical ex-
amination including inspection and palpation of the perineal
lesion, as well as a digital rectal examination are necessary. To
exclude pneumonia or another febrile infectious disease at sites
other than the urinary tract, image diagnostic tools such as ultra-
sound, x-ray, and CT are useful.
Signiﬁcantly higher rates of antibiotic resistance have been
found in Asia as compared with Europe and North America,40 thus
broad-spectrum antimicrobials should be empirically administered
based on monitoring of local antibiotic resistance patterns by
uropathogens. Such empiric antimicrobial therapy can be guided by
recent prior urine culture results, when available.41 A prospective
randomized study showed that clinical and bacteriological out-
comes were signiﬁcantly improved when long-term indwelling
catheters were replaced before initiation of antimicrobial ther-
apy.42 A few days after initiating that therapy, the effectiveness of
the empirical drug should be assessed, with deescalation to the
narrowest spectrum antimicrobial agent recommended, as guided
by urine culture results.
Even though a variety of different types of urethral catheters are
available, including those impregnated with silver or antibiotics, no
randomized study has presented ﬁndings supporting a role for
their use to prevent CAUTI related to long-term bladder drainage.43
Alternative methods of bladder drainage with suprapubic catheter
may be considered, but its evidence of efﬁcacy in preventing CAUTI
remains limited. Based on the clinical ﬁndings, suprapubic cathe-
ters are associated with a low incidence of urethral injury and
stricture, but have similar rates of upper tract damage such ves-
icoureteral reﬂux, renal or bladder calculi, and symptomatic uri-
nary tract infections as well as cancers, compared with urethral
catheters.44,45 Thus, to prevent CAUTI, it is strongly recommended
to avoid unnecessary urinary catheterization and minimize the
duration of catheterization by close surveillance.46,47 To shorten the
catheterization period, a nurse-generated or electronic-based
reminder, as well as a stop-order system for removal of the uri-
nary catheter have been reported to be effective.48e50 Furthermore,
urinary catheter care bundles and infection control programs have
also been shown to reduce the rate of CAUTI, including educational
and training regarding catheter indications, aseptic catheter
insertion techniques, hygienic practices, and surveillance and per-
formance feedback systems.51,52 No recommendation can be given
for routine use of antibiotic prophylaxis for prevention of CAUTI.
Needless to say, routine use of antimicrobial prophylaxis for pre-
vention of CAUTI for either short- or long-term urinary catheteri-
zation is not recommended, as that would result in an increase in
resistant pathogens.53e55
4.1. Obstructive pyelonephritis secondary to stones
Obstructive pyelonephritis complicated by urolithiasis can be
life-threatening, and requires prompt diagnosis and treatment,
including medical as well as surgical intervention to rescue the
affected patient. For prompt diagnosis of complicated UTI and ac-
curate evaluation of physical condition, imaging diagnosis should
be considered for males or any patient with a history of DM, uro-
lithiasis, urological abnormality, relapsing UTI, febrile UTI, urine pH
7.0, and/or renal insufﬁciency.56e58 Ultrasound, plain abdominal
X-ray imaging, and abdominal and pelvic CT are the most
commonly utilized imaging tools. A Japanese study of 1363 patients
revealed that female patients outnumber males by 2.2 times,
although the mortality rate for all affected patients was 2.3%.
Multivariate analysis showed that the predictive risk factors for
death from disease during hospitalization were age > 80 years,
systemic inﬂammatory response syndrome (SIRS), disseminatedPlease cite this article in press as: Yamamoto S, Prevention and treatme
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ness, and solitary kidney.59
E. coli is the most frequently isolated uropathogen, while others
related include P. mirabilis, Klebsiella, and Enterococci, though some
cases show multiple uropathogens. Candida albicans as well can be
isolated from the urine of these patients.59e61 Although a urine
culture is deﬁnitely required prior to initiation of antimicrobial
therapy, the results of a bladder urine culture do not always
correlate with those of stone and renal pelvic cultures.55 In febrile
UTI with urosepsis cases, two blood culture examinations must be
performed for differentiation between true bacteremia and
contamination.
For decompression of the renal collecting system, retrograde
ureteral catheterization (RUC) and percutaneous nephrostomy
(PCN) are equally effective,62 with the decision of which mode of
drainage to choose primarily based on logistical factors such as
surgeon preference and stone characteristics,63 though patients
who have undergone RUC may have a worse result as compared
with those who have received PCN.64 Some studies have shown
that training background, favorable physician reimbursement,
timing of intervention, and patient-speciﬁc factors are signiﬁcant
drivers in this decision-making process,65,66 though neither mo-
dality has been demonstrated to be superior for promoting more
rapid recovery after drainage.
5. Conclusion
A complicated UTI is a relapsing refractory condition, and can be
life-threatening because of patient predisposing factors as well as
the worldwide spread of multi-drug resistant bacteria. Attending
physicians must choose wisely among appropriate treatment ap-
proaches based on a correct understanding of the etiologies, as well
as available diagnostic strategies and treatment options for affected
patients.
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